Biochemistry, Genetics and Molecular Biology
Exon
69%
Screening
46%
Prevalence
38%
USH2A
32%
Genetic Disorder
31%
Autosomal Dominant Inheritance
31%
GJB2
27%
DNA Extraction
27%
Allele
27%
Autosomal Recessive Inheritance
24%
Vision
23%
Aminoacyl tRNA Synthetase
23%
Genetic Counseling
23%
Gene Linkage
23%
LDL Receptor
23%
Factor H
23%
Receptor Gene
23%
Evoked Otoacoustic Emission
23%
Genetic Association
23%
Ranibizumab
23%
Epidemiological Data
23%
Familial Hypercholesterolemia
23%
Phenylketonuria
23%
Haplogroup
23%
Haplotype
23%
Minor Allele Frequency
23%
Retrospective Study
23%
Maternal Age
23%
Mitochondrial DNA
23%
Genotyping
22%
DNA Sequence
20%
Nonsyndromic Deafness
19%
Genetics
17%
Isoform
17%
Age-Related Maculopathy Susceptibility 2
17%
Psychomotor Development
11%
Screening Test
11%
Enzyme
11%
Missense
11%
Gene Sequence
11%
Retinal
11%
Retinitis pigmentosa
10%
Genetic Screening
9%
Population Research
7%
Auditory Screening
7%
Calcium-Binding Protein
5%
Indel
5%
Gene Mutation
5%
Synapse
5%
Exocytosis
5%
Medicine and Dentistry
Hearing Impairment
100%
Neonatal Infant
66%
Retina Dystrophy
34%
Waardenburg Syndrome
29%
Screening
27%
Disease
27%
Retrospective Study
25%
Fundus (Eye)
23%
Providencia
23%
Rubella
23%
Evoked Otoacoustic Emission
23%
Retinol Dehydrogenase
23%
Congenital Disorder
23%
Diagnosis
23%
Retinitis pigmentosa
23%
Genetic Counseling
23%
Odds Ratio
23%
Congenital Malformation
22%
Auditory Screening
18%
Usher Syndrome
16%
Molecular Diagnosis
16%
Retinopathy
15%
Leber Congenital Amaurosis
13%
Genetic Disorder
13%
Screening Test
13%
Bruch's Membrane
11%
Autosomal Dominant Inheritance
11%
Exon
11%
Retinal Pigment Epithelium
11%
Drusen
11%
Macular Degeneration
11%
Low Vision
11%
Pediatrician
11%
DNA Extraction
11%
Table Salt
11%
Visual Impairment
9%
Vision
8%
Prematurity
7%
Otoacoustic Emission
7%
Iris
7%
Prevalence
6%
Autosomal Recessive Inheritance
6%
Pharmacology, Toxicology and Pharmaceutical Science
Hearing Impairment
46%
Congenital Malformation
34%
Prevalence
23%
Serine Protease HTRA1
23%
Complement Factor H
23%
Wet Macular Degeneration
23%
Congenital Disorder
23%
Ranibizumab
23%
Rubella
23%
Retrospective Study
23%
Waardenburg Syndrome
23%
Retina Maculopathy
17%
Retinopathy
15%
Antiangiogenic Therapy
11%
Microtia
11%
Population Study
11%
Table Salt
11%
Prematurity
8%
Antiangiogenic
5%
Visual Impairment
5%
Age Related Macular Degeneration
5%
Cross-Sectional Study
5%
Recurrent Disease
5%
